Skip to content
10-Q

Quarterly Report

Corbus Pharmaceuticals Holdings, Inc. CRBP

0001193125-25-277748

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 17.55M sh
Shares Diluted Q3 2025 · Sep 30, 2025 12.31M sh
Shares Diluted Q3 2025 · Sep 30, 2025 12.25M sh
Shares Diluted Q3 2025 · Sep 30, 2024 12.01M sh
Shares Diluted Q3 2025 · Sep 30, 2024 10.49M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$48.57M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$30.85M
Short Term Investments Q3 2025 · Sep 30, 2025 $77M
Short Term Investments Q3 2025 · Dec 31, 2024 $131.86M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $26.98M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $17.2M
Stockholders Equity Q3 2025 · Sep 30, 2025 $92.15M
Stockholders Equity Q3 2025 · Jun 30, 2025 $110.99M
Stockholders Equity Q3 2025 · Dec 31, 2024 $142.43M
Stockholders Equity Q3 2025 · Sep 30, 2024 $150.5M
Stockholders Equity Q3 2025 · Jun 30, 2024 $125.54M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$6.91M
Current Liabilities Q3 2025 · Sep 30, 2025 $17.06M
Current Liabilities Q3 2025 · Dec 31, 2024 $11.82M
Total Liabilities Q3 2025 · Sep 30, 2025 $17.37M
Total Liabilities Q3 2025 · Dec 31, 2024 $13.45M
Current Assets Q3 2025 · Sep 30, 2025 $107.57M
Current Assets Q3 2025 · Dec 31, 2024 $152.98M
Total Assets Q3 2025 · Sep 30, 2025 $109.51M
Total Assets Q3 2025 · Dec 31, 2024 $155.88M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.90
Eps Diluted Q3 2025 · Sep 30, 2025 −$4.73
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.15
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.92
Eps Basic Q3 2025 · Sep 30, 2025 −$1.90
Eps Basic Q3 2025 · Sep 30, 2025 −$4.73
Eps Basic Q3 2025 · Sep 30, 2024 −$1.15
Eps Basic Q3 2025 · Sep 30, 2024 −$2.92
Sga Expense Q3 2025 · Sep 30, 2025 $3.56M
Sga Expense Q3 2025 · Sep 30, 2025 $11.66M
Sga Expense Q3 2025 · Sep 30, 2024 $4.7M
Sga Expense Q3 2025 · Sep 30, 2024 $12.68M
Rd Expense Q3 2025 · Sep 30, 2025 $20.86M
Rd Expense Q3 2025 · Sep 30, 2025 $51.69M
Rd Expense Q3 2025 · Sep 30, 2024 $10.81M
Rd Expense Q3 2025 · Sep 30, 2024 $23.44M
Net Income Q3 2025 · Sep 30, 2025 −$23.34M
Net Income Q3 2025 · Sep 30, 2025 −$57.98M
Net Income Q3 2025 · Sep 30, 2024 −$13.78M
Net Income Q3 2025 · Sep 30, 2024 −$30.68M
Operating Income Q3 2025 · Sep 30, 2025 −$24.42M
Operating Income Q3 2025 · Sep 30, 2025 −$63.34M
Operating Income Q3 2025 · Sep 30, 2024 −$15.51M
Operating Income Q3 2025 · Sep 30, 2024 −$36.12M